The Association of Clinical Research Professionals (ACRP) announced that over the next 4 years they'll be investing $4 million into the development of a new proprietary training curriculum designed for clinical research professionals.
The Association of Clinical Research Professionals (ACRP) announced that over the next 4 years they'll be investing $4 million into the development of a new proprietary training curriculum designed for clinical research professionals. The 80+ new courses--the first of which are expected in January 2014--will cover 14 topic areas, and be designed for multiple learning formats. The heaviest focus will be on eLearning and online courses, all of which are to be hosted on the new Learning Management System "that allows for administration, documentation, tracking, reporting, and delivery of eLearning training solutions."
ACRP's investment aims to position the organization as the preeminent provider of professional development resources for the clinical research enterprise.
Read the full release here.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
POETYK PsA-2 Trial Shows Efficacy of Sotyktu as an Oral Therapy for Psoriatic Arthritis
March 11th 2025Sotyktu (deucravacitinib) demonstrated significant efficacy in improving psoriatic arthritis symptoms compared to placebo in the Phase III POETYK PsA-2 trial, with a well-tolerated safety profile.